718 results on '"Strafella, Antonio P."'
Search Results
2. The role of AI and machine learning in the diagnosis of Parkinson's disease and atypical parkinsonisms
3. Multimodal visual system analysis as a biomarker of visual hallucinations in Parkinson’s disease
4. The challenging quest of neuroimaging: From clinical to molecular-based subtyping of Parkinson disease and atypical parkinsonisms
5. Cognition affects gait adaptation after split-belt treadmill training in Parkinson's disease
6. Advancing Parkinson's Disease Research in Canada: The Canadian Open Parkinson Network (C-OPN) Cohort
7. Multiple system atrophy with amyloid-β predominant Alzheimer’s disease neuropathologic change
8. Beta amyloid deposition and cognitive decline in Parkinson’s disease: a study of the PPMI cohort
9. Imaging pathological tau in atypical parkinsonisms: A review
10. Metabolic imaging and plasticity
11. Correction to: Multimodal visual system analysis as a biomarker of visual hallucinations in Parkinson’s disease
12. Combining transcranial brain stimulation and PET/SPECT molecular imaging
13. Proprioceptive recalibration following implicit visuomotor adaptation is preserved in Parkinson’s disease
14. Fatty acid amide hydrolase binding is inversely correlated with amygdalar functional connectivity: a combined positron emission tomography and magnetic resonance imaging study in healthy individuals
15. Disrupted salience network dynamics in Parkinson's disease patients with impulse control disorders
16. Covering Basic Needs on Molecular Imaging
17. PET imaging of synaptic density in Parkinsonian disorders
18. Contributions of sex, depression, and cognition on brain connectivity dynamics in Parkinson’s disease
19. VMAT2 availability in Parkinson’s disease with probable REM sleep behaviour disorder
20. The Interaction Between Neuroinflammation and β-Amyloid in Cognitive Decline in Parkinson’s Disease
21. Network Patterns of Beta-Amyloid Deposition in Parkinson’s Disease
22. The clinical significance of lower limb tremors
23. PET imaging of synaptic density in Parkinsonian disorders.
24. Covering Basic Needs on Molecular Imaging.
25. Tau in Atypical Parkinsonisms: A Meta‐Analysis of in vivo PET Imaging Findings
26. Preliminary Assessment of Reference Region Quantification and Reduced Scanning Times for [18F]SynVesT-1 PET in Parkinson’s Disease
27. DRD2 Genotype-Based Variants Modulates D2 Receptor Distribution in Ventral Striatum
28. Brain degeneration in Parkinson’s disease patients with cognitive decline: a coordinate-based meta-analysis
29. Imaging behavioural complications of Parkinson’s disease
30. Deep TMS of the insula using the H-coil modulates dopamine release: a crossover [11C] PHNO-PET pilot trial in healthy humans
31. Author Correction: Report from a multidisciplinary meeting on anxiety as a non-motor manifestation of Parkinson’s disease
32. Contribution of transcranial magnetic stimulation to assessment of brain connectivity and networks
33. Report from a multidisciplinary meeting on anxiety as a non-motor manifestation of Parkinson’s disease
34. Preliminary Assessment of Reference Region Quantification and Reduced Scanning Times for [ 18 F]SynVesT-1 PET in Parkinson's Disease.
35. Rethinking NBM DBS: Intermittent stimulation improves sustained attention in Parkinson's disease
36. [18F]AV-1451 binding to neuromelanin in the substantia nigra in PD and PSP
37. Structural and Molecular Imaging for Clinically Uncertain Parkinsonism
38. First-in-Human PET Imaging of [18F]SDM-4MP3: A Cautionary Tale
39. Molecular Imaging of Addictive Behavior in Idiopathic Parkinson's Disease
40. PET Evaluation of Microglial Activation in Non-neurodegenerative Brain Diseases
41. New and Old TSPO PET Radioligands for Imaging Brain Microglial Activation in Neurodegenerative Disease
42. First-in-Human PET Imaging of [ 18 F]SDM-4MP3: A Cautionary Tale.
43. Imaging microglial activation and amyloid burden in amnestic mild cognitive impairment
44. Correction to: Multimodal visual system analysis as a biomarker of visual hallucinations in Parkinson’s disease
45. Multimodal visual system analysis as a biomarker of visual hallucinations in Parkinson’s disease
46. Reversible neurological and brain MRI changes following COVID-19 vaccination: A case report
47. Chapter 15 - The challenging quest of neuroimaging: From clinical to molecular-based subtyping of Parkinson disease and atypical parkinsonisms
48. Neuroimaging of rapid eye movement sleep behavior disorder and its relation to Parkinson's disease
49. Imaging insights into basal ganglia function, Parkinson's disease, and dystonia
50. Effect of mild cognitive impairment on the patterns of neural activity in early Parkinson's disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.